Thyroid embryology, surgical anatomy include artery,venous, lymphatic drainage,signs and symptoms, type of conditions investigations,preop prep types of surgeries,post OP complications
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Thyroid: Complete Surgical Reference
Sources: Sabiston Textbook of Surgery (21e), Schwartz's Principles of Surgery (11e), Current Surgical Therapy (14e)
1. EMBRYOLOGY
Median Thyroid Anlage
Thyroid development begins in the third week of gestation with a thickening of the endodermal epithelium on the floor of the pharynx (foregut) at the foramen cecum, at the base of the tongue. This outpouching of endoderm descends caudally alongside the developing myocardial cells, forming a bilobed diverticulum connected to the tongue by the thyroglossal duct.
- The thyroglossal duct becomes solid in the 5th week, then fragments and disappears
- Obliteration leaves the foramen cecum superiorly and, when present, the pyramidal lobe inferiorly
- The thyroid reaches its final position anterior to the trachea by the 7th week
- Thyroid follicles form by 8 weeks; colloid formation begins by week 11; thyroid hormone is produced by week 10
Lateral Thyroid Anlage
Originates from the pharyngeal endoderm (4th and 5th pharyngeal pouches) and fuses with the median anlage at the 5th week. The ultimobranchial bodies from these pouches give rise to the calcitonin-secreting parafollicular C cells (the median anlage does not carry these cells). The lateral anlage comprises approximately one-third of the total thyroid mass.
Developmental Anomalies
| Anomaly | Description |
|---|---|
| Thyroglossal duct cyst | Incomplete obliteration of the duct; presents as a midline neck mass at/near the hyoid that moves on tongue protrusion and swallowing; can become infected or develop fistula |
| Lingual thyroid | Undescended thyroid at the foramen cecum; may cause dysphagia, dysphonia, hypothyroidism |
| Ectopic thyroid | Anywhere from foramen cecum to anterior mediastinum |
| Pyramidal lobe | Persistent inferior portion of thyroglossal duct (present in ~50% of people) |
Treatment of thyroglossal duct cyst: Sistrunk procedure - excision of the cyst, entire thyroglossal duct tract, and the central portion of the hyoid bone (first described 1920).
2. SURGICAL ANATOMY
Gross Anatomy
- Butterfly/shield-shaped gland, bilobed, connected by the isthmus
- Located anterior to the trachea (C5-T1 vertebral level)
- Enclosed in the pretracheal fascia; attached to the trachea/larynx by the ligament of Berry (posterior suspensory ligament)
- Weight: approximately 25-30 g in adults
- Pyramidal lobe: ascends from the isthmus toward the hyoid in ~50% of people
Arterial Supply
| Artery | Origin | Territory |
|---|---|---|
| Superior thyroid artery (bilateral) | External carotid artery | Superior poles; also supplies superior parathyroids |
| Inferior thyroid artery (bilateral) | Thyrocervical trunk of subclavian artery | Midpoles; major supply to all parathyroids |
| Thyroid ima artery | Aorta or innominate artery directly (~2% of people) | Isthmus and inferior poles (midline path) |
The inferior thyroid artery runs cephalad and posterior to the carotid sheath before entering the midthyroid lobe. The recurrent laryngeal nerve (RLN) typically crosses the inferior thyroid artery perpendicularly - this intersection is a critical surgical landmark. Parathyroid supply: traditionally thought to derive mainly from the inferior thyroid artery, but there is significant anatomic variation; superior parathyroids may receive supply from the superior thyroid artery alone, inferior alone, or both.
Venous Drainage
| Vein | Drains Into |
|---|---|
| Superior thyroid veins | Internal jugular veins (parallel to superior thyroid arteries) |
| Middle thyroid veins | Internal jugular veins (lateral aspect of midlobe; highly variable) |
| Inferior thyroid veins | Innominate (brachiocephalic) veins (drain inferiorly from inferior poles) |
Lymphatic Drainage
Rich and extensive lymphatic network. Follows a standardized 7-level cervical nomenclature:
- Level VI (central compartment) - receives the bulk of primary lymphatic drainage from the thyroid; includes perithyroidal nodes bounded by the carotid arteries laterally, hyoid superiorly, and innominate artery inferiorly
- Level VII - superior mediastinal nodes (inferior extension of level VI)
- Levels II, III, IV - lateral jugular chain (secondary drainage)
- Level Vb - inferior posterior triangle
The central neck (Level VI) is the first-echelon nodal basin for thyroid cancer. Skip metastases directly to lateral neck (level II-IV), bypassing level VI, occur in ~12% of papillary thyroid cancer cases.
Key Nerves
1. Recurrent Laryngeal Nerve (RLN)
- Right RLN: loops under the subclavian artery; runs in a more oblique, lateral course
- Left RLN: loops under the aortic arch; runs in the tracheoesophageal groove more medially
- Both nerves enter the larynx via the cricothyroid membrane, innervating all intrinsic laryngeal muscles except the cricothyroid
- Injury: unilateral = hoarseness; bilateral = aphonia + stridor (life-threatening)
- Berry's ligament is the most dangerous zone for RLN injury (nerve may branch or course anteriorly here)
2. External Branch of Superior Laryngeal Nerve (EBSLN)
- Runs with the superior thyroid artery before branching; innervates the cricothyroid muscle (voice pitch)
- Injury causes loss of high-pitched phonation (Amelita Galli-Curci sign); less dramatic than RLN injury but significant for singers/speakers
3. Vagus nerve - in the carotid sheath; also at risk in extensive neck dissections
Parathyroid Glands
- Usually 4 glands (2 superior, 2 inferior), averaging 30-40 mg each
- Superior parathyroids: more constant position, posterior to the upper thyroid lobes near the cricothyroid junction
- Inferior parathyroids: more variable; can be in the thyrothymic ligament or anterior mediastinum
- At risk during thyroidectomy from devascularization, manipulation, or inadvertent resection
3. HISTOLOGY (Brief)
- Follicular cells (principal cells): surround colloid-filled follicles; produce T3 and T4
- Colloid: mainly thyroglobulin; the thyroid's hormone storage unit
- Parafollicular C cells: in the interfollicular stroma; produce calcitonin; derived from ultimobranchial bodies; site of origin of medullary thyroid cancer (MTC)
4. CONDITIONS OF THE THYROID
A. Hypothyroidism
| Condition | Key Features |
|---|---|
| Hashimoto's thyroiditis (autoimmune) | Most common cause of hypothyroidism; anti-TPO and anti-Tg antibodies; lymphocytic infiltrate with Hurthle cell change |
| Subacute (de Quervain's) thyroiditis | Post-viral; painful thyroid, elevated ESR, transient thyrotoxicosis followed by hypothyroidism; self-limiting |
| Riedel's thyroiditis | Extremely rare; dense fibrosis replacing the gland; rock-hard, fixed gland; may cause airway obstruction, dysphagia; treat with corticosteroids/tamoxifen; surgery for biopsy/tracheal decompression |
| Acute suppurative thyroiditis | Bacterial (Staph/Strep); fever, severe unilateral pain/swelling (usually left-sided); may form abscess; treat with antibiotics + drainage |
| Iatrogenic | Post-thyroidectomy, post-RAI, medications (amiodarone, lithium, etc.) |
B. Hyperthyroidism
| Condition | Key Features |
|---|---|
| Graves' disease | Most common cause; TSH-R stimulating antibodies (TSAb); diffuse goiter; ophthalmopathy; dermopathy; acropachy |
| Toxic multinodular goiter (TMNG) | Multiple autonomously functioning nodules; common in iodine-deficient areas; older patients |
| Solitary toxic adenoma | Single hyperfunctioning nodule; hot on scan; suppressed TSH |
| Amiodarone-induced thyrotoxicosis | Type I (iodine-induced, excess synthesis) or Type II (destructive thyroiditis) |
C. Goiter
- Endemic goiter: iodine deficiency (most common worldwide cause of thyroid enlargement)
- Nontoxic multinodular goiter: most common type in iodine-sufficient areas; heterogeneous, asymmetric
- Substernal goiter: extension into the superior mediastinum; can cause SVC compression (Pemberton's sign), tracheal deviation, dysphagia
D. Thyroid Nodules
- Very common (50% of adults by ultrasound)
- 5-15% are malignant on FNA
- Risk factors for malignancy: age <20 or >70, male sex, prior radiation, family history of MTC/MEN2, rapidly growing, hard/fixed, hoarseness, cervical lymphadenopathy
E. Thyroid Cancer
| Type | Frequency | Origin | Features |
|---|---|---|---|
| Papillary thyroid cancer (PTC) | ~80% | Follicular cells | Psammoma bodies; nuclear grooves/pseudoinclusions; BRAF V600E mutation; spreads via lymphatics; excellent prognosis |
| Follicular thyroid cancer (FTC) | ~10% | Follicular cells | FNA cannot distinguish from follicular adenoma (capsular/vascular invasion required); hematogenous spread to bone/lung; more common with iodine deficiency |
| Hurthle cell carcinoma | ~3-5% | Follicular cells (oncocytic) | RAI-resistant; more aggressive behavior |
| Medullary thyroid cancer (MTC) | ~2% | Parafollicular C cells | Secretes calcitonin (marker); amyloid stroma; 25% hereditary (RET mutations - MEN2A/2B, familial MTC) |
| Anaplastic thyroid cancer (ATC) | <2% | Unknown (de-differentiated) | Most aggressive; often locally invasive; median survival 3-6 months |
| Primary thyroid lymphoma | Rare | Lymphoid | Usually B-cell; associated with Hashimoto's thyroiditis |
5. SIGNS AND SYMPTOMS
Hypothyroidism
Fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, bradycardia, menorrhagia, cognitive slowing, myxedema, periorbital puffiness, hoarse voice, delayed relaxation phase of deep tendon reflexes, goiter (Hashimoto's), myxedema coma (severe/untreated)
Hyperthyroidism
Weight loss with increased appetite, heat intolerance, palpitations, tachycardia/AF, tremor, anxiety/irritability, sweating, diarrhea, oligomenorrhea, warm/moist skin
Graves-specific:
- Exophthalmos/proptosis (infiltrative ophthalmopathy)
- Pretibial myxedema
- Thyroid acropachy (subperiosteal new bone formation in metacarpals)
- Onycholysis
- Thyroid bruit/thrill
- Enlarged pyramidal lobe
Local Compressive Symptoms (any large thyroid mass)
- Dysphagia
- Stridor/dyspnea
- Hoarseness (RLN invasion/compression)
- Pemberton's sign (SVC obstruction with arm elevation - neck vein engorgement, facial plethora)
- Horner's syndrome (if sympathetic chain involvement)
Signs of Malignancy
- Hard, fixed, painless mass
- Cervical lymphadenopathy
- Rapid growth
- Hoarseness (RLN fixation)
6. INVESTIGATIONS
Biochemical
| Test | Use |
|---|---|
| TSH | First-line screen; suppressed in hyperthyroidism; elevated in hypothyroidism |
| Free T4 / Free T3 | Assess severity of dysfunction; T3-toxicosis in early Graves/toxic nodules |
| Anti-TPO antibodies | Hashimoto's thyroiditis (~95% positive); also elevated in Graves' (~75%) |
| Anti-thyroglobulin antibodies | Hashimoto's; interferes with Tg measurement |
| TSH-receptor antibodies (TSAb/TRAb) | Diagnostic of Graves' disease; elevated in ~90% |
| Thyroglobulin (Tg) | Tumor marker for DTC after total thyroidectomy; >1-2.5 ng/mL suggests recurrence |
| Calcitonin | Diagnostic/follow-up marker for MTC; elevated even in C-cell hyperplasia |
| CEA | Also elevated in MTC; correlates with tumor burden |
| Serum calcium / PTH | Preop and postop; especially in MEN2A (concurrent hyperparathyroidism) |
Imaging
| Modality | Use |
|---|---|
| Neck ultrasound | First-line imaging; characterizes nodule size, echogenicity, vascularity, calcifications, lymph nodes; guides FNA; ACR TI-RADS system for risk stratification |
| Radioiodine scan (123I) | Determines functional status (hot vs. cold nodules); essential if TSH is suppressed; hot nodules are rarely malignant |
| Technetium-99m scan | Similar to 123I but less radiation; assesses trapping but not organification |
| CT neck/chest | Substernal goiter, locally invasive cancer, tracheal deviation/compression; pre-thoracic surgery planning |
| MRI | Soft tissue detail; orbital involvement (Graves' ophthalmopathy); avoids iodinated contrast that would delay RAI therapy |
| PET-CT | FDG-avid metastases; RAI-negative but Tg-positive disease; ATC/MTC |
Cytology/Pathology
Fine Needle Aspiration Biopsy (FNAB) - the key diagnostic test for thyroid nodules
Reported using the Bethesda System for Reporting Thyroid Cytopathology (BSRTC):
| Bethesda Category | Risk of Malignancy | Management |
|---|---|---|
| I - Nondiagnostic/Unsatisfactory | N/A | Repeat FNA |
| II - Benign | <3% | Clinical follow-up |
| III - Atypia of Undetermined Significance (AUS) | 6-30% | Repeat FNA or molecular testing |
| IV - Follicular Neoplasm (FN) | 10-40% | Molecular testing or lobectomy |
| V - Suspicious for Malignancy | 50-75% | Thyroid lobectomy or total thyroidectomy |
| VI - Malignant | >97% | Total thyroidectomy |
Molecular testing (Afirma Gene Sequencing Classifier, ThyroSeq v3) - used for Bethesda III/IV nodules to refine malignancy risk and reduce unnecessary operations
Preop-Specific Tests
- Serum calcium and PTH (parathyroid assessment)
- Preoperative voice assessment / laryngoscopy (vocal cord function)
- Chest X-ray / CT (substernal goiter, tracheal deviation)
- Echocardiogram (if thyrotoxic with AF or cardiac dysfunction)
- Pregnancy test (if applicable)
7. PREOPERATIVE PREPARATION
Achieving Euthyroid State (for hyperthyroidism)
This is essential before elective thyroidectomy to prevent thyroid storm.
Antithyroid drugs:
- Methimazole (MMI): 10-30 mg TDS then once daily; first choice; inhibits TPO-mediated organification and iodotyrosine coupling; euthyroid in ~6 weeks
- Propylthiouracil (PTU): 100-300 mg TDS; also inhibits peripheral T4→T3 conversion; preferred in pregnancy (lower transplacental transfer) and thyroid storm; associated with hepatotoxicity so use is restricted
- Note: Methimazole associated with congenital aplasia cutis so PTU preferred in first trimester
Beta-blockade:
- Propranolol (non-selective): controls adrenergic symptoms (tremor, palpitations, heat intolerance); also inhibits peripheral T4→T3 conversion
- Continued until euthyroid
Iodine preparation (for Graves' disease/hyperthyroid patients):
- Lugol's solution or SSKI (saturated solution of potassium iodide) given within 10 days of surgery
- Decreases vascularity of the gland (reduces intraoperative bleeding by up to 50%), reduces hormone synthesis and release (Wolff-Chaikoff effect)
- Historically pioneered by Charles Mayo and Henry Plummer
Other preop steps:
- Biochemical assessment (TSH, free T4/T3, calcium, PTH, CBC)
- Neck ultrasound review
- FNAB review / staging workup
- Preoperative laryngoscopy / voice assessment (mandatory for prior neck surgery, voice changes, posterior ETE, bulky nodal disease; AAES guidelines recommend selective use)
- Cross-sectional imaging for large/substernal/invasive goiters
- Rule out pheochromocytoma before any surgery in MEN2 kindreds (serum metanephrines/urine catecholamines)
- For MEN2A: check serum calcium for concurrent hyperparathyroidism
8. TYPES OF THYROID SURGERY
A. Extent of Resection
| Operation | Definition | Indications |
|---|---|---|
| Total thyroidectomy | Removal of all visible thyroid tissue; <1 g remnant (near-total) | DTC (bilateral/multifocal), Graves' disease (definitive), large bilateral goiter, MTC, ATC |
| Thyroid lobectomy (hemithyroidectomy) | Removal of one lobe + isthmus + pyramidal lobe | Unilateral nodule (low-risk PTC <1 cm or Bethesda IV/V, unilateral toxic adenoma, unilateral benign goiter) |
| Subtotal thyroidectomy | 3-5 g bilateral remnant preserved | Less commonly done today; historically used for Graves' to preserve function |
| Near-total thyroidectomy | <1 g remnant at ligament of Berry | Similar indications to total thyroidectomy |
| Isthmusectomy | Isthmus and pyramidal lobe only | Isthmic nodule, Sistrunk (thyroglossal duct cyst) |
B. Nodal Dissection (for thyroid cancer)
| Procedure | Compartment | Indication |
|---|---|---|
| Central neck dissection (CND) | Level VI (± VII) | Biopsy-proven or intraoperatively confirmed central neck nodal disease in DTC; prophylactic CND may be considered in T3/T4 PTC or if guides adjuvant therapy |
| Lateral neck dissection (modified radical) | Levels II-IV (± Vb) | Biopsy-proven lateral neck nodal metastases; replaces radical neck dissection (preserves SCM, IJV, CN XI) |
| Radical neck dissection | Levels I-V + SCM + IJV + CN XI | Rarely required; only for extensive local invasion |
C. Surgical Approaches
| Approach | Description |
|---|---|
| Conventional (open) Kocher incision | Low transverse collar incision, 2-3 cm above sternal notch; standard approach |
| Minimally invasive video-assisted thyroidectomy (MIVAT) | Small central incision; suitable for small glands/nodules |
| Robotic thyroidectomy | Remote-access: transaxillary, retroauricular (BABA - bilateral axillo-breast approach); avoids visible neck scar; longer operative time; limited by gland size |
| Transoral endoscopic thyroidectomy vestibular approach (TOETVA) | Through the oral vestibule; truly scarless; increasing adoption for smaller glands |
D. Ablative (Non-Surgical) Alternatives
| Technique | Use |
|---|---|
| Radioactive iodine (131I) | Graves' disease, toxic nodules, DTC adjuvant after thyroidectomy |
| Radiofrequency ablation (RFA) | Benign symptomatic nodules (low to intermediate ATA/TI-RADS); small toxic adenomas; 65-77% volume reduction at 6-12 months; preferred over surgery when preserving function matters |
| Microwave ablation / Laser ablation | Similar indications to RFA |
9. INTRAOPERATIVE TECHNIQUE (Key Steps)
- Positioning: Supine, arms tucked; back raised 20°; neck extended with shoulder roll; head ring
- Incision: Kocher (transverse collar incision, 2-3 cm above sternal notch)
- Subplatysmal flaps: raised superiorly to thyroid cartilage, inferiorly to sternal notch
- Strap muscle division: midline raphe opened; strap muscles retracted laterally (not cut unless adherent tumor)
- Superior pole: superior thyroid artery and vein ligated close to the gland (to protect the EBSLN)
- Parathyroid identification: superior and inferior parathyroids identified and preserved with their blood supply; autotransplantation to sternomastoid if devascularized
- RLN identification: nerve identified before dividing any posterior tissue; traced from its entry at the tracheoesophageal groove upward; crosses the inferior thyroid artery; protected throughout
- Ligament of Berry: thyroid released from trachea; most dangerous zone for RLN (may branch anteriorly here)
- Isthmus divided: specimen removed
- Intraoperative neuromonitoring (IONM): electromyographic monitoring via specialized ETT electrodes; used to confirm RLN integrity before/after each lobe; loss of signal prompts cessation to prevent bilateral injury
10. POSTOPERATIVE COMPLICATIONS
Immediate (0-24 hours)
| Complication | Details |
|---|---|
| Neck hematoma | Most feared immediate complication; expanding hematoma can cause fatal airway obstruction; re-explore immediately at bedside; incidence ~1% |
| Bilateral RLN injury | Acute stridor, aphonia; may require emergency reintubation/tracheostomy |
| Thyroid storm | If inadequately prepared hyperthyroid patient; triggered by surgical manipulation; treat with PTU/MMI, beta-blockers, iodine, corticosteroids, cooling, ICU care |
| Airway obstruction | From hematoma, tracheomalacia (after longstanding goiter), bilateral RLN palsy, or laryngeal edema |
Short-Term (days to weeks)
| Complication | Details |
|---|---|
| Hypocalcemia / hypoparathyroidism | Most common complication after total thyroidectomy; from parathyroid devascularization or inadvertent removal; symptoms: perioral numbness, Chvostek's sign, Trousseau's sign, carpopedal spasm, tetany; treat with IV/oral calcium + calcitriol |
| Hungry bone syndrome | In previously hyperthyroid patients; severe/prolonged hypocalcemia despite normal PTH; low phosphate, low magnesium; related to high preoperative bone turnover |
| Unilateral RLN palsy | Hoarseness, breathy voice; 1-2% in experienced hands; may recover in 3-6 months (transient neuropraxia); permanent if nerve divided |
| EBSLN injury | Loss of high-pitch phonation; inability to project voice |
| Wound infection | Uncommon; cellulitis or deep space infection |
| Seroma | Fluid collection; managed by aspiration |
| Chyle leak | If left-sided dissection extends to thoracic duct junction; chylous drainage; treat with low-fat diet or medium-chain triglyceride diet; rarely needs surgical repair |
Long-Term
| Complication | Details |
|---|---|
| Permanent hypoparathyroidism | If PTH undetectable at 6+ months; lifelong calcium + calcitriol supplementation |
| Permanent RLN palsy | Hoarseness; voice therapy; injection laryngoplasty or medialization thyroplasty for selected cases |
| Hypothyroidism | Expected after total thyroidectomy; levothyroxine replacement; goal TSH: suppressed (<0.1) for high-risk DTC, low-normal (0.5-2.0) for low-risk DTC and benign disease |
| Recurrent hyperthyroidism | After subtotal thyroidectomy for Graves'; insufficient remnant ablation |
| Tumor recurrence | PTC: monitored with Tg, neck ultrasound; local, regional, or distant |
| Tracheomalacia | After longstanding substernal goiter; post-extubation stridor; usually self-limiting |
| Keloid/hypertrophic scar | Especially in predisposed individuals |
| Pneumothorax | Rare; from extensive neck dissection near apex of lung |
Complication Rates (High-Volume Surgeons)
- Temporary RLN palsy: ~2-5%
- Permanent RLN palsy: ~0.5-1%
- Temporary hypocalcemia: ~10-20% (total thyroidectomy)
- Permanent hypoparathyroidism: ~1-2%
- Neck hematoma: ~0.5-1%
Quick Reference: Signs
| Sign | Condition |
|---|---|
| Pemberton's sign | Substernal goiter - facial plethora/cyanosis + neck vein engorgement when arms raised |
| Chvostek's sign | Hypocalcemia - facial twitch on tapping facial nerve |
| Trousseau's sign | Hypocalcemia - carpal spasm with BP cuff inflation |
| Bruit/thrill over thyroid | Graves' disease (hypervascular gland) |
| Kocher's sign | Tracheal compression - stridor with lateral compression of thyroid |
| Berry's sign | Absence of carotid pulsations (obliterated by malignant thyroid) |
| Galli-Curci sign | Loss of high-pitched phonation (EBSLN injury) |
References: Sabiston Textbook of Surgery 21e (Chapter 73: Thyroid); Schwartz's Principles of Surgery 11e (Chapter 38: Thyroid); Current Surgical Therapy 14e (Complications of Thyroidectomy; Surgery for Graves' Disease)
This is a shared conversation. Sign in to Orris to start your own chat.